Treatment of Dysuria and Discharge with Negative Testing
Treat this patient empirically for non-gonococcal urethritis (NGU) with doxycycline 100 mg orally twice daily for 7 days, as this represents the first-line therapy for culture-negative urethritis in sexually active young men. 1, 2, 3
Diagnostic Confirmation
Before initiating treatment, confirm that urethritis is actually present by documenting at least one of the following objective findings:
- Mucopurulent or purulent urethral discharge on examination 4
- ≥5 white blood cells per oil immersion field on Gram stain of urethral secretions 4
- Positive leukocyte esterase test on first-void urine OR ≥10 WBCs per high-power field on microscopic examination of first-void urine 4
Critical caveat: If none of these objective signs are present, defer treatment and retest for N. gonorrhoeae and C. trachomatis with close follow-up, as symptoms alone without documented inflammation are insufficient for treatment 4. However, the absence of pyuria does not exclude sexually transmitted urethritis, as urethral swabs and first-catch urine have low sensitivity (29-62%) for detecting polymorphonuclear leukocytes in various pathogens 1.
Recommended Treatment Regimen
Doxycycline 100 mg orally twice daily for 7 days is the preferred first-line therapy 1, 2, 3:
- This regimen has replaced azithromycin 1 g single dose as first-line due to emerging antimicrobial resistance concerns, particularly with Mycoplasma genitalium 1, 3
- Doxycycline should be taken with adequate fluids to reduce esophageal irritation risk 2
- If gastric irritation occurs, administer with food or milk, as absorption is not significantly affected 2
Alternative regimen if doxycycline cannot be used:
- Azithromycin extended course: 500 mg orally as a single dose on day 1, then 250 mg daily for 4 additional days (total 5 days) 1, 3
- This extended azithromycin regimen is preferred over the traditional 1 g single dose to reduce resistance development 3
Likely Etiologies in This Clinical Scenario
With negative testing for chlamydia, gonorrhea, and negative urine culture, the most probable causes include:
- Mycoplasma genitalium - implicated in up to one-third of NGU cases 4
- Ureaplasma urealyticum - another common cause of nonchlamydial NGU 4, 2
- Trichomonas vaginalis - occasionally causes NGU 4
- Herpes simplex virus - can cause NGU in some cases 4
Important note: Specific diagnostic tests for M. genitalium and U. urealyticum are not routinely indicated in initial management because detection is difficult and would not alter first-line therapy 4. However, testing for M. genitalium becomes important if symptoms persist after initial treatment 1, 3.
Essential Management Steps
Partner management:
- Refer all sexual partners from the preceding 60 days for evaluation and treatment 4, 1
- Partners should receive the same empiric treatment regimen even if asymptomatic 4
Sexual abstinence:
- Instruct the patient to abstain from sexual intercourse until 7 days after therapy is initiated 4
- Both patient and partners must complete treatment before resuming sexual activity 4
Follow-up instructions:
- Return for evaluation only if symptoms persist or recur after completing therapy 4
- Symptoms alone without objective signs of urethral inflammation are not sufficient basis for re-treatment 4
Management of Persistent or Recurrent Symptoms
If symptoms persist after completing the initial 7-day doxycycline course:
First, assess compliance and re-exposure: If the patient did not complete treatment or was re-exposed to an untreated partner, re-treat with the initial regimen 4
If compliant and no re-exposure occurred:
- Perform wet mount examination and culture of intraurethral swab for T. vaginalis 4
- Consider testing for M. genitalium if not previously done, as this pathogen shows extremely high treatment failure rates (60-70%) with standard regimens 1, 3, 5
- Treat with metronidazole 2 g orally single dose PLUS erythromycin base 500 mg orally four times daily for 7 days 4
For confirmed M. genitalium with macrolide resistance: Consider moxifloxacin 400 mg daily for 7-14 days 1
Common Pitfalls to Avoid
- Do not treat based on symptoms alone without documenting objective signs of urethritis, as this leads to unnecessary antibiotic exposure 4
- Avoid azithromycin 1 g single dose as first-line therapy due to resistance concerns, particularly with M. genitalium 1, 3
- Do not perform routine testing for U. urealyticum or M. genitalium in initial management, as it does not change first-line treatment 4
- Ensure partner treatment to prevent reinfection, which is a major cause of persistent symptoms 4, 1